Search

everythinglearnresearchcommunity

for

Search:↓

Certain ESR1 gene variations may affect hormone levels and fat distribution in women with high male hormone levels.

A rare ovarian tumor caused a postmenopausal woman to develop male-like features, which improved after surgery.

Women with PCOS have a higher risk of metabolic syndrome and need lifestyle changes and treatment.

Women with only irregular periods or excess hair have a better hormone profile than those with full PCOS, but both groups are similar, indicating a need for better PCOS diagnosis methods.

Lower hair zinc and copper levels found in Turkish males with hair loss; higher BMI linked to less hair zinc.

Different diagnostic criteria greatly affect PCOS diagnosis rates in teenagers.

Lower vaspin levels in the blood may indicate a better response to fertility treatment in women with PCOS.

Women with PCOS have lower adiponectin hormone levels and are more likely to have insulin resistance.

Women with nonclassical congenital adrenal hyperplasia may have a higher risk of fertility issues and miscarriages, and should get genetic counseling.

Hair mesotherapy showed improvement in hair growth and thickness without side effects.

High-dose radioactive iodine therapy does not harm fertility in thyroidectomy patients.

There's no clear link between female pattern hair loss, insulin resistance, and metabolic syndrome.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

Cholesterol sulfate buildup due to a genetic mutation disrupts the skin barrier, leading to the scaling skin seen in X-linked ichthyosis.

Hormonal treatments like birth control pills can improve acne in women with excess hair growth and hormone imbalances.

A holistic approach, including medical treatments, lifestyle changes, and mental health support, is crucial for managing hirsutism in women.

The 6-year-old Somalian girl fully recovered from her symptoms after successful surgery and treatment.

The review suggests that while many AKR1C3 inhibitors show promise for treating certain cancers, more research is needed to confirm their effectiveness in humans.

The most common skin issues in females with Polycystic Ovary Syndrome (PCOS) are excessive hair growth, hair loss, oily skin, acne, dark skin patches, and skin tags, which may be linked to hormone and insulin levels.

Women with PCOS are more likely to have depression and anxiety.

Women with early-onset baldness should be checked for early bone loss, but bone density doesn't change with baldness severity.

Vitamin D deficiency is linked to a higher chance of metabolic syndrome in women with PCOS.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

Taking DHEA for a year is generally safe for postmenopausal women but may cause acne and more facial hair without improving metabolism or aging.

DHEA reduction may be linked to frontal fibrosing alopecia, but more research is needed.

Testosterone and DHEA can benefit women's health but must be prescribed carefully due to potential risks.

Chronic DHEA supplementation slightly increases testosterone in hair but stays within safe limits.

Researchers had trouble finding enough participants for a trial on DHEA's effects on postmenopausal women's sexual desire.

The over-the-counter supplement DHEA could make COVID-19 worse, especially in diabetics and people with G6PD deficiency.

DHEA boosts bone cell growth and differentiation in elderly stem cells.